UNSPSC 51241525: Epinephrine/pilocarpine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP105. This VA Drug Class (OP105) classifies this compound as belonging to the group ANTIGLAUCOMA COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51241525 Epinephrine/pilocarpine, a Commodity code, covers pharmaceutical products that state and local governments procure through cooperative purchasing agreements and direct supply contracts. State and local buyers use this code to source branded and generic medications, including epinephrine auto-injectors and pilocarpine ophthalmic solutions, for hospital systems, clinics, correctional facilities, public health agencies, and emergency medical services. The work involves vendor qualification, pricing negotiation, supply chain compliance (including FDA registration, Good Manufacturing Practices certification, and Drug Supply Chain Security Act adherence), and product delivery through authorized pharmaceutical wholesalers.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (S1070000015802) to establish multiple contracts for generic multi-source pharmaceuticals and over-the-counter products distributed across participating state and local government facilities in Minnesota and Oregon. The RFP, due March 26, 2026, requires vendors to supply products through three authorized wholesalers — AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC — and to maintain pricing flexibility through flat-price, net-price, or WAC-minus structures. Evaluation weights 75 percent on price competitiveness, 10 percent on fixed pricing for contract term, and 5 percent each on EDI capability, administrative fee compliance, and data format requirements. The contract term is two years for new responders with optional extensions, or aligned with existing expiration dates through June 30, 2028 for incumbents. Vendors must carry $5 million commercial general liability, $2 million network security and privacy liability, and $2 million professional liability insurance, and all products must have at least one-year expiration dates from manufacture with a six-month minimum shelf life. Performance penalties range from $200 to $1,500 per violation for late reporting, missed onboarding, or class-of-trade denials, and vendors pay a 3 percent administrative fee on all contract purchases.